Form 4: Bio-Rad Laboratories Director, Allison Schwartz, Reports Stock Award

Director Allison Schwartz reports receiving 57 shares of Bio-Rad B Common Stock on August 26, 2024.

Summary

• On August 26, 2024, Allison Schwartz, a director at Bio-Rad Laboratories, Inc., acquired 57 shares of Bio-Rad B Common Stock.
• The shares were acquired at a price of $0.
• Following the transaction, Schwartz beneficially owns 3,996 shares of Bio-Rad B Common Stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports a transaction. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment, as insider buying can be interpreted as a sign of confidence in the company.

Key Dates